Author: Au, Lewis; Boos, Laura Amanda; Swerdlow, Anthony; Byrne, Fiona; Shepherd, Scott T.C.; Fendler, Annika; Turajlic, Samra
Title: Cancer, COVID-19, and antiviral immunity: the CAPTURE study Cord-id: rxb6zfoc Document date: 2020_9_3
ID: rxb6zfoc
Snippet: The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation amongst cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.
Document: The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation amongst cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.
Search related documents:
Co phrase search for related documents- absolute risk and adaptive immunity: 1
- absolute risk and adaptive innate: 1
- absolute risk and longitudinal study: 1, 2, 3, 4, 5, 6
- absolute risk and lung cancer: 1, 2
- accurate picture and long term immunity: 1
- accurate picture and longitudinal follow: 1
Co phrase search for related documents, hyperlinks ordered by date